TRANSFORMED LYMPHOMA
Clinical trials for TRANSFORMED LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED LYMPHOMA trials appear
Sign up with your email to follow new studies for TRANSFORMED LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on Hard-to-Treat lymphoma
Disease control Recruiting nowThis early-phase study tests whether a patient's own immune cells, modified to target a protein called CD19 on cancer cells, can safely treat several types of non-Hodgkin lymphoma that have come back or not responded to standard treatments. About 36 adults with relapsed or refrac…
Matched conditions: TRANSFORMED LYMPHOMA
Phase: PHASE1 • Sponsor: C. Babis Andreadis • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
New antibody therapy aims to keep lymphoma at bay after transplant
Disease control Recruiting nowThis early-phase study tests a drug called mosunetuzumab given after a stem cell transplant for people with aggressive B cell lymphomas that have come back or not responded to treatment. Mosunetuzumab is an engineered antibody that helps the body's immune T cells find and kill ca…
Matched conditions: TRANSFORMED LYMPHOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 17, 2026 01:51 UTC
-
New hope for High-Risk lymphoma: maintenance drug aims to prevent relapse
Disease control Recruiting nowThis study tests whether the drug acalabrutinib, taken after cell therapy (like stem cell transplant or CAR T-cells), can help prevent relapse in patients with very high-risk large B-cell lymphoma. About 24 adults aged 18-70 will participate. The goal is to see if the drug is tol…
Matched conditions: TRANSFORMED LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:02 UTC